Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
Submitted by
admin
on January 1, 2018 - 3:08pm
Source:
GoinPharma
News Tags:
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
Headline:
Time for weighing things up for Kare Schultz, Teva CEO: group gains $8bn in capitalization in two months
Do Not Allow Advertisers to Use My Personal information
